Cargando…

T‐cell adoptive immunotherapy for BK nephropathy in renal transplantation

INTRODUCTION: BK virus (BKPyV) nephropathy occurs in 1%‐10% of kidney transplant recipients, with suboptimal therapeutic options. CASE: A 54‐year‐old woman received a transplant in March 2017. BKPyV was detected at 1.5 × 10(2) copies/mL within a month, necessitating halving of mycophenolate and addi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jahan, Sadia, Scuderi, Carla, Francis, Leo, Neller, Michelle A, Rehan, Sweera, Crooks, Pauline, Ambalathingal, George R, Smith, Corey, Khanna, Rajiv, John, George T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816252/ https://www.ncbi.nlm.nih.gov/pubmed/32608543 http://dx.doi.org/10.1111/tid.13399

Ejemplares similares

'Off-the-shelf’ allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies
por: Sinha, Debottam, et al.
Publicado: (2021)

SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants
por: Panikkar, Archana, et al.
Publicado: (2022)

Rapid whole‐blood assay to detect SARS‐CoV‐2‐specific memory T‐cell immunity following a single dose of AstraZeneca ChAdOx1‐S COVID‐19 vaccine
por: Lineburg, Katie E, et al.
Publicado: (2021)

Ex vivo expansion of human T cells for adoptive immunotherapy using the novel Xeno-free CTS Immune Cell Serum Replacement
por: Smith, Corey, et al.
Publicado: (2015)

Proteome‐wide analysis of T‐cell response to BK polyomavirus in healthy virus carriers and kidney transplant recipients reveals a unique transcriptional and functional profile
por: Ambalathingal, George R, et al.
Publicado: (2020)

Ablation of CD8(+) T cell recognition of an immunodominant epitope in SARS-CoV-2 Omicron variants BA.1, BA.2 and BA.3
por: Swaminathan, Srividhya, et al.
Publicado: (2022)

Pre-clinical development of T-cell immunotherapy for covid-19
por: Smith, C., et al.
Publicado: (2021)

Pre-emptive and therapeutic adoptive immunotherapy for nasopharyngeal carcinoma: Phenotype and effector function of T cells impact on clinical response
por: Smith, Corey, et al.
Publicado: (2017)

Immunotherapy: ADOPTIVE T CELL IMMUNOTHERAPY FOR SARS-COV-2
por: Henden, A., et al.
Publicado: (2023)

Rapid detection of SARS‐CoV‐2‐specific memory T‐cell immunity in recovered COVID‐19 cases
por: Lineburg, Katie E, et al.
Publicado: (2020)

Prophylactic and therapeutic adenoviral vector-based multivirus-specific T-cell immunotherapy for transplant patients
por: Dasari, Vijayendra, et al.
Publicado: (2016)

Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinoma
por: Smith, Corey, et al.
Publicado: (2021)

Limited Recognition of Highly Conserved Regions of SARS-CoV-2
por: Swaminathan, Srividhya, et al.
Publicado: (2022)

Profiling HPV-16–specific T cell responses reveals broad antigen reactivities in oropharyngeal cancer patients
por: Bhatt, Kunal H., et al.
Publicado: (2020)

Correction: Profiling HPV-16–specific T cell responses reveals broad antigen reactivities in oropharyngeal cancer patients
por: Bhatt, Kunal H., et al.
Publicado: (2022)

Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis
por: Pender, Michael P., et al.
Publicado: (2020)

Adoptive T-cell immunotherapy for ganciclovir-resistant CMV disease after lung transplantation
por: Holmes-Liew, Chien-Li, et al.
Publicado: (2015)

A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice
por: Dasari, Vijayendra, et al.
Publicado: (2022)

Native BK Polyomavirus Nephropathy in an Orthotopic Heart Transplant Patient
por: Thompson, Zachary M., et al.
Publicado: (2023)

Epstein–Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis
por: Pender, Michael P, et al.
Publicado: (2014)

BK virus nephropathy is not always alone
por: Esmaili, Haydarali, et al.
Publicado: (2015)

BK Virus Infection and BK-Virus-Associated Nephropathy in Renal Transplant Recipients
por: Borriello, Margherita, et al.
Publicado: (2022)

Adoptive T‐cell therapy targeting Epstein–Barr virus as a treatment for multiple sclerosis
por: Smith, Corey, et al.
Publicado: (2023)

BK nephropathy in the native kidneys of patients with organ transplants: Clinical spectrum of BK infection
por: Vigil, Darlene, et al.
Publicado: (2016)

BK Virus Replication in the Glomerular Vascular Unit: Implications for BK Virus Associated Nephropathy
por: Popik, Waldemar, et al.
Publicado: (2019)

Optimal use of plasma and urine BK viral loads for screening and predicting BK nephropathy
por: Boan, Peter, et al.
Publicado: (2016)

BK Virus and Nephropathy in Kidney Transplant Recipients
por: Einollahi, B., et al.
Publicado: (2016)

BK Polyomavirus-Induced Nephropathy in Native Kidney
por: Munjal, Ripudaman S, et al.
Publicado: (2023)

Quantitation of BK Virus DNA for Diagnosis of BK Virus-Associated Nephropathy in Renal Transplant Recipients
por: Sung, Heungsup, et al.
Publicado: (2008)

A new approach for cellular immunotherapy of nasopharyngeal carcinoma
por: Smith, Corey, et al.
Publicado: (2012)

Native kidney BK nephropathy: A case report
por: Al Zein, Said, et al.
Publicado: (2019)

BK Virus Nephropathy: Prevalence, Impact and Management Strategies
por: Sharma, Rajeev, et al.
Publicado: (2020)

The immunophenotyping of different stages of BK virus allograft nephropathy
por: Li, Ping, et al.
Publicado: (2019)

BK Virus-Associated Nephropathy after Renal Transplantation
por: Funahashi, Yasuhito
Publicado: (2021)

BK virus nephropathy in a heart transplant recipient
por: Nieto-Ríos, John Fredy, et al.
Publicado: (2021)

Evaluation of leflunomide for the treatment of BK viremia and biopsy proven BK nephropathy; a single center experience
por: Nesselhauf, Nicole, et al.
Publicado: (2016)

Polyomavirus-Specific Cellular Immunity: From BK-Virus-Specific Cellular Immunity to BK-Virus-Associated Nephropathy?
por: Dekeyser, Manon, et al.
Publicado: (2015)

BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy
por: Bruminhent, Jackrapong, et al.
Publicado: (2019)

Combined detection of urine specific gravity and BK viruria on prediction of BK polyomavirus nephropathy in kidney transplant recipients
por: Chen, Xu-Tao, et al.
Publicado: (2020)

Incidence of BK Virus Nephropathy (BKVN) in Renal Transplant Recipients
por: Pezeshgi, A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_po640cof6fcadh17drgkv0jh72